Wingless-INT (WNT) Family

The Wingless-INT (WNT) family is an important family of cell signaling proteins, covering multiple members, including WNT1, WNT2, WNT3, etc. This family plays a key regulatory role in cell development, tissue repair and disease occurrence.

The WNT signaling pathway plays an important role in embryonic development and is involved in the formation of the embryonic axis and the development of the nervous system. It regulates embryonic cell fate decisions, ensuring the correct generation of different cell types. In addition, the WNT signaling pathway also plays an important role in tissue repair and regeneration in adulthood, promoting stem cell self-renewal and tissue regeneration.

In terms of cell proliferation and differentiation, the WNT signaling pathway is critical for maintaining normal tissue growth and development. It regulates the proliferation and differentiation of stem cells and affects the decision of cell fate. By regulating intracellular signal transduction, WNT family members participate in the process of cell proliferation, differentiation and tissue maintenance.

The WNT signaling pathway is closely related to the occurrence and development of various diseases. In cancer, aberrant activation of the WNT signaling pathway can lead to uncontrolled proliferation, invasion and metastasis of tumor cells while maintaining tumor stem cell properties. Therefore, researchers have conducted in-depth studies on the role of WNT family members in tumorigenesis and progression to find new therapeutic strategies and targets.

In addition, the WNT signaling pathway is also related to the occurrence and development of various neurological diseases. Aberrant WNT signaling may lead to defects in nervous system development and neurodegenerative diseases. Researchers are working hard to explore the specific mechanism of WNT signaling pathway in these diseases, in order to provide new methods and drug targets for the treatment of neurological diseases.

In summary, the WNT family plays an important regulatory role in cell development, tissue repair and disease occurrence. An in-depth study of the WNT signaling pathway will help us better understand the mechanism of cell signaling and reveal its application potential in disease treatment and regenerative medicine.

Wnt Family Targets

Wnt Inhibitors

DKK1	DKK2	DKK3	DKK4	DKKL1	FRZB
IGFBP4	SFRP1	SFRP2	SFRP4	sFRP-5	SOST/Sclerostin
SOSTDC1	WIF1

Wnt Intracellular Signaling

c-Abl/ABL1	MASH1/ASCL1	Calmodulin 1/CALM1	CAMKI	CaMKII alpha/CAMK2A	CaMKII beta/CAMK2B	CaMKII/CAMK2G	Casein Kinase 1 alpha
Casein Kinase 1 delta	CSNK1E	CSNK1G1	CK2 alpha/CSNK2A1	Casein Kinase 2 beta	beta-Catenin	DIXDC1	c-Fos
c-Jun	JunD/Jun-D	MAP3K7/TAK1	MAPK10/JNK3	JNK1	JNK2	Calcineurin A/PPP3CA	Calcineurin B/PPP3R1
PKC alpha/PRKCA	PRKCB	PKC delta/PRKCD	PKC epsilon/PRKCE	PRKCG/PKCG	PKC iota	GLRX3/PRKCT	PRKCZ / PKC zeta
Protein Kinase D2/PRKD2	PKC nu	ROCK2	TGFB1I1	Ubiquitin/UBB	VANGL2

Wnt Ligands (Wnts)

WNT10A	WNT10B	WNT16	Wnt2	WNT2B	WNT3A
Wnt4	Wnt5a	Wnt5b	Wnt6	Wnt7a	WNT8A
WNT8B	WNT9B

Wnt Receptors

FZD1/Frizzled 1	Frizzled 10	Frizzled 2	Frizzled 4	Frizzled 5	Frizzled 6	Frizzled-9/FZD9	LRP1
LRP10	LRP11	LRP8/ApoER2	LRPAP1	MUSK	ROR1	ROR2	RYK
ST7	VANGL2

Wnt Signaling Modulators

Biglycan	DAB2	GPC2/Glypican 2	Glypican 3/GPC3	Glypican 6/GPC6	KREMEN1
LEF1	Myocilin	NDP/EVR2	NEUROD1	RSPO1	RSPO2
RSPO3	RSPO4	Syndecan-1/CD138	Syndecan-2	Syndecan-3	Syndecan-4
SHISA4	TSPAN12

Wnt Signaling Pathway Inhibitors

Wnt inhibitors are a class of drugs or compounds used to inhibit the activity of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in normal cell development and tissue repair, but when the pathway is abnormally activated, it may lead to the occurrence and development of a variety of diseases, including cancer, neurological diseases and musculoskeletal diseases. Therefore, researchers strive to find and develop Wnt inhibitors to block or regulate abnormally activated Wnt signaling pathways, which have potential therapeutic and disease intervention effects.

Wnt inhibitors can inhibit the Wnt signaling pathway through various mechanisms. A common strategy is to block the activity of Wnt signaling by targeting key molecules in it. For example, inhibiting the stability of nuclear β-catenin protein in Wnt signaling, or blocking the binding of Wnt to its receptor Frizzled, etc. These inhibitors can inhibit the growth and spread of tumors by interfering with key steps in the Wnt signaling pathway and inhibiting malignant properties such as cell proliferation, invasion and metastasis.

Another strategy is to affect cellular function by modulating effector genes downstream of the Wnt signaling pathway. These effector genes play important roles in cell proliferation, differentiation and fate determination. By interfering with the expression of these genes, Wnt inhibitors can regulate the function and fate of cells, thereby affecting the occurrence and development of diseases.

The research and development of Wnt inhibitors have broad application prospects. In addition to their potential applications in cancer therapy, Wnt inhibitors may also have therapeutic potential for other diseases, such as neurological, bone and cardiovascular diseases. However, further studies are needed to validate and optimize the efficacy and safety of these inhibitors in order to apply them in clinical practice.

In summary, Wnt inhibitors are a class of drugs or compounds used to intervene in abnormally activated Wnt signaling pathways. They have potential therapeutic and disease intervention effects, especially in cancer and other diseases associated with abnormalities in the Wnt signaling pathway. With further understanding and research on the Wnt signaling pathway, the development of Wnt inhibitors will help provide more effective treatment options for patients.

The Wnt Signaling Pathway: Intracellular Signaling and Genetic Discoveries

The Wnt signaling pathway is a complex network of protein interactions that functions most commonly in embryonic development and cancer, but is also involved in normal physiological processes in adult animals. The Wnt signaling pathway is a signal transduction pathway of a set of multiple downstream channels stimulated by the binding of the ligand protein Wnt and membrane protein receptors. Through this pathway, the extracellular signal is transmitted into the cell through the activation process of the intracellular segment of the cell surface receptor.

The Wnt signaling pathway presents two signaling modes between cells: intercellular communication (paracrine) or self-cell communication (autocrine). The Wnt signaling pathway is highly conserved genetically among animals, and is very similar among different animal species.

In 1982, the Wnt gene was first discovered in mouse breast cancer. Since the activation of this gene depends on the insertion of mouse breast cancer-related virus genes, it was named Int1 gene at that time. Subsequent studies have shown that the Int1 gene plays an important role in the normal embryonic development of mice. It is similar to the Wingless gene in Drosophila and can control the axial development of embryos. Since then, a large number of studies have suggested the importance of the Int1 gene in the embryonic development of the nervous system. Due to the similarity of the two genes and protein functions, the researchers combined Wingless and Int1 and named it the Wnt gene. The human Wnt gene is mapped to 12q13.

Path classification

1. Canonical Wnt/β-catenin signaling pathway (Canonical Wnt/β-catenin pathway), which activates the expression of target genes in the nucleus; Wnt family secreted protein, Frizzled family transmembrane receptor protein Dishevelled (Dsh), glycogen synthesis kinase 3 (GSK3), APC, Axin, β-catenin and TCF/LEF family transcription regulators constitute the classic pathway;
2. Planar cell polarity pathway, which is involved in the activation of JNK and the rearrangement of cytoskeleton;
3. Wnt/Ca pathway, activate phospholipase C (PLC) and protein kinase C (PKC);
4. Intracellular pathways that regulate the orientation of the spindle and asymmetric cell division.

signaling pathway

The canonical Wnt pathway (Wnt/β-catenin pathway) leads to regulation of gene transcription and is thought to be negatively regulated in part by the SPATS1 gene.

The Wnt/β-catenin pathway is one of the Wnt pathways that cause β-catenin to accumulate in the cytoplasm and eventually translocate to the nucleus as a transcriptional coactivator/LEF family of transcription factors belonging to TCF.

Without Wnt, β-catenin does not accumulate in the cytoplasm because there is a destruction complex that normally degrades it. This destruction complex includes the following proteins: Axin, adenomatous E. coli (APC), protein phosphatase 2A (PP2A), glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α). It degrades β-catenin by targeting it for ubiquitination, which then sends it to the proteasome for digestion.

Wnt signaling begins when Wnt proteins bind to the N-terminal cellular cysteine-rich domain of Frizzled (Fz) family receptors. These receptors span the plasma membrane seven times and constitute a distinct family of G protein-coupled receptors (GPCRs). However, to facilitate Wnt signaling, co-receptors and interactions between Wnt proteins and Fz receptors may be required. Examples include lipoprotein receptor-related protein (LRP)-5/6, receptor tyrosine kinase (RTK) and ROR2. However, whenever Wnt binds Fz and LRP5/6, phosphorylation of the destruction complex is blocked and its function disrupted. Phosphorylation by other proteins in the destruction complex then binds Axin to the cytoplasmic tail of LRP5/6. Axin is dephosphorylated, and its stability and concentration levels are reduced. Dsh is then activated by phosphorylation and its DIX and PDZ domains inhibit the activity of the GSK3 destruction complex. This allows β-catenin to accumulate and localize to the nucleus, followed by gene transduction and TCF/LEF (T cell factor/lymphoid enhancer factor) transcription factors to induce the transcription of Wnt's final target genes, inducing subsequent cellular responses. β-catenin recruits other transcriptional coactivators such as BCL9, Pygopus and Parafibromin/Hyrax. Thanks to new high-throughput proteomic studies, the complexity of the transcriptional complex assembled by β-catenin is beginning to emerge. The promiscuity of β-catenin-interacting proteins has complicated our understanding: BCL9 and Pygopus have indeed been reported to have several functions that are independent of β-catenin (and thus, possibly independent of the Wnt signaling pathway).

 

Exploring the Role of Wnt Ligands in Cell Signaling and Disease

After being secreted between cells, Wnt ligands initiate the Wnt signaling pathway by binding to Frizzled (FZD) receptors and LRP5/6 co-receptors on the cell surface. This binding activates FZD receptors, triggering a series of signal transduction events that influence cellular behavior and function.

Wnt ligand signaling pathways can be categorized as canonical and non-canonical. The canonical pathway primarily involves the regulation of β-catenin. In the inactive state, β-catenin is phosphorylated and degraded. However, the binding of Wnt ligands inhibits β-catenin degradation, resulting in its stabilization and translocation into the nucleus. Inside the nucleus, stable β-catenin binds to the transcription factor LEF/TCF, promoting the transcription of Wnt target genes and thereby regulating cell proliferation, differentiation, and fate.

The expression and function of Wnt ligands are spatiotemporally specific. They play a crucial role in embryonic development, participating in processes such as the formation of the embryonic axis, organ differentiation, and morphogenesis. Furthermore, Wnt ligands also contribute to tissue repair and regeneration in adulthood by influencing stem cell self-renewal and tissue regenerative processes.

Abnormal expression or dysfunction of Wnt ligands is closely associated with the occurrence and development of various diseases. For instance, in cancer, overexpression or abnormal activation of Wnt ligands can promote tumor cell proliferation, invasion, and metastasis. Therefore, researchers have conducted in-depth studies to unravel the regulatory mechanisms and functions of Wnt ligands, aiming to understand their roles in disease development and treatment.

Unveiling the Role and Therapeutic Potential of Wnt Receptors

Wnt receptors are crucial membrane-bound molecules that interact with Wnt ligands and facilitate signal transmission. The main Wnt receptors include the Frizzled (FZD) receptor family and the low-density lipoprotein receptor-related protein 5/6 (LRP5/6) co-receptors. These receptors play a vital role on the cell surface by regulating the initiation and transduction of Wnt signaling.

The Frizzled receptors form the core receptor family of the Wnt signaling pathway, consisting of multiple members such as FZD1, FZD2, FZD3, and more. These receptors specifically bind Wnt ligands through their extracellular domains and transmit signals through their intracellular domains. Activation of Frizzled receptors triggers a series of signal transduction events, involving multiple signaling molecules and pathways that ultimately regulate the physiological functions of cells.

In addition to Frizzled receptors, the low-density lipoprotein receptor-related protein 5/6 (LRP5/6) is another crucial Wnt receptor. LRP5/6 receptors form complexes with Frizzled receptors, promoting the initiation of Wnt signaling. The extracellular domains of LRP5/6 receptors bind to Wnt ligands, enhancing the activity of Frizzled receptors and facilitating the transmission of Wnt signals.

Wnt receptors play a significant role in cell development, tissue morphogenesis, and disease occurrence. They regulate cell proliferation, differentiation, and fate determination and are involved in embryonic development as well as the maintenance of adult tissues. Abnormal expression or malfunction of Wnt receptors is closely associated with various diseases, including cancer, bone diseases, and nervous system disorders.

Studying Wnt receptors deepens our understanding of the regulatory mechanisms of the Wnt signaling pathway and its connection to related diseases. Furthermore, Wnt receptors are considered potential therapeutic targets because modulating Wnt receptor signaling may help regulate abnormal Wnt signaling pathways and intervene in the treatment of related diseases.

Wnt Signaling Modulators

Wnt signaling modulators encompass a diverse array of molecules that exert control over the Wnt signaling pathway. This crucial cellular communication pathway regulates various developmental and physiological processes. The role of these modulators is pivotal in fine-tuning the intensity and duration of Wnt signaling, which is essential for ensuring appropriate cellular responses and maintaining tissue homeostasis.

Wnt signaling modulators can be broadly classified into two main groups: agonists and antagonists. Agonists, also known as Wnt signaling enhancers, promote the activation of the Wnt pathway. They achieve this by stabilizing Wnt ligands, facilitating their secretion, or enhancing their binding to the Frizzled (FZD) family of receptors and co-receptors, such as LRP5/6. These actions ultimately activate downstream signaling cascades, resulting in the expression of target genes responsible for cellular responses such as proliferation and differentiation.

On the other hand, antagonists, or Wnt signaling inhibitors, dampen or suppress Wnt pathway activity. They employ diverse mechanisms to interfere with different steps of the Wnt signaling cascade. Some antagonists directly bind to Wnt ligands, preventing their interaction with receptors. Others inhibit the activity of FZD receptors or LRP5/6 co-receptors, thereby impeding signal transmission into the cell. Additionally, certain modulators target intracellular components of the Wnt pathway, such as Dishevelled (DVL) or β-catenin, to halt signal transduction.

Maintaining a delicate balance between Wnt agonists and antagonists is crucial for proper tissue development and homeostasis. Dysregulation of this equilibrium can contribute to various diseases, including cancer, neurodegenerative disorders, and developmental defects.

Wnt signaling modulators are involved in multiple physiological processes, ranging from embryogenesis and tissue regeneration to immune responses. They play critical roles in stem cell maintenance, tissue repair, and cell fate determination. Given their intricate involvement in diverse cellular functions, they represent attractive targets for therapeutic interventions in numerous diseases.

Efforts to comprehend the functions and molecular mechanisms of Wnt signaling modulators constitute a thriving area of research. Scientists strive to unravel their roles in development and disease while searching for potential drug targets that could modulate Wnt pathway activity for therapeutic purposes.

In conclusion, Wnt signaling modulators encompass a diverse group of molecules that intricately regulate the activity of the Wnt signaling pathway. Their effects rely on a complex interplay of agonists and antagonists, ensuring precise control of Wnt pathway activity and contributing to normal development and tissue homeostasis. Disruptions in this delicate balance can lead to disease pathogenesis, highlighting the potential of Wnt signaling modulators as promising targets for therapeutic interventions.

Research area of WNT Family

The research area of the Wnt family encompasses a wide range of topics and disciplines due to the diverse functions and implications of Wnt signaling in various biological processes. Some key research areas related to the Wnt family include:

1. Developmental Biology: Wnt signaling plays a critical role in embryonic development, controlling processes such as cell fate determination, tissue patterning, and organogenesis. Researchers investigate the precise spatiotemporal regulation of Wnt signaling during embryogenesis and its impact on developmental outcomes.
2. Stem Cell Biology: Wnt signaling is intimately involved in the regulation of stem cell self-renewal, differentiation, and maintenance. Understanding the role of Wnt signaling in stem cell biology is crucial for advancing regenerative medicine and tissue engineering approaches.
3. Cancer Biology: Dysregulation of Wnt signaling is implicated in various types of cancer. Researchers study the aberrant activation or suppression of Wnt signaling in tumor initiation, progression, metastasis, and therapy resistance. Targeting the Wnt pathway for cancer therapy is an active area of investigation.
4. Neurobiology: Wnt signaling plays a crucial role in neural development, axon guidance, synapse formation, and neurogenesis. Dysfunction of Wnt signaling has been implicated in neurological disorders, such as Alzheimer's disease, Parkinson's disease, and autism spectrum disorders. Researchers study the impact of Wnt signaling on neural development and its contribution to neurological diseases.
5. Skeletal Biology: Wnt signaling is involved in the regulation of bone development, remodeling, and homeostasis. Research focuses on understanding the role of Wnt signaling in osteoblast and osteoclast differentiation, bone formation, and bone-related disorders, such as osteoporosis and osteoarthritis.
6. Tissue Regeneration and Repair: Wnt signaling is critical for tissue regeneration and repair in various organs and tissues, including the liver, intestine, skin, and heart. Researchers explore the mechanisms by which Wnt signaling contributes to tissue regeneration and investigate therapeutic strategies to enhance tissue repair processes.
7. Therapeutic Targeting: Given the involvement of Wnt signaling in numerous diseases, including cancer, neurological disorders, and degenerative conditions, researchers are actively investigating the development of Wnt pathway modulators as potential therapeutic agents. This includes the identification of small molecules, antibodies, and gene therapies that can modulate Wnt signaling for therapeutic purposes.

In summary, the research areas related to the Wnt family encompass developmental biology, stem cell biology, cancer biology, neurobiology, skeletal biology, tissue regeneration and repair, as well as therapeutic targeting. Understanding the intricate mechanisms of Wnt signaling and its implications in various biological processes is of significant interest to scientists and holds promise for therapeutic interventions in numerous diseases.

References:

[1]. Li F, Chong ZZ, Maiese K. Windingthrough the WNT pathway during cellular development and demise. HistolHistopathol. 2006 Jan;21(1):103-24. PubMed ID: 16267791

[2]. Katoh M, Katoh M. Comparative genomicson Wnt5a and Wnt5b genes. Int J Mol Med. 2005 Apr;15(4):749-53. PubMed ID:15754042

[3]. Li F, Chong ZZ, Maiese K. Vital elementsof the Wnt-Frizzled signaling pathway in the nervous system. Curr NeurovascRes. 2005 Oct;2(4):331-40. PubMed ID: 16181124

[4] Martin-Orozco E, Sanchez-Fernandez A, Ortiz-Parra I, Ayala-San Nicolas M. WNT Signaling in Tumors: The Way to Evade Drugs and Immunity. Front Immunol. 2019 Dec 20;10:2854. doi: 10.3389/fimmu.2019.02854. PMID: 31921125; PMCID: PMC6934036. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934036/

[5] Pai SG, Carneiro BA, Mota JM, et al. Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol. 2017;10(1):101. Published 2017 May 5. doi:10.1186/s13045-017-0471-6 https://pubmed.ncbi.nlm.nih.gov/28476164/

[6]. Willert, K. & Nusse, R. Wnt proteins. Cold Spring Harbor perspectives in biology 4, a007864 doi: 10. 1101 / cshperspect. a007864 (2012).

[7]. Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452, doi: 10. 1038 / nature01611 (2003).

[8].Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414, doi: 10. 1038 / nature01593 (2003).

[9]. Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C. & Garcia, K. C. Structural basis of Wnt recognition by Frizzled. Science 337, 59-64, doi: 10. 1126 / science. 1222879 (2012).